| [1] |
Han Y. 2010. Tai Ping Sheng Hui Fang yu Song Dai She Hui (《太平圣恵方》与宋代社会) [Taiping Holy Prescriptions for Universal Relief and the compilation during the early Song Dynasty]. |
| [2] |
Liao CP, Liu XC, Dong SQ, An M, Zhao L, et al. 2021. Investigation of the metabolites of five major constituents from Berberis amurensis in normal and pseudo germ-free rats. |
| [3] |
Roy NS, Park NI, Kim NS, Park Y, Kim BY, et al. 2022. Comparative transcriptomics for genes related to berberine and berbamine biosynthesis in Berberidaceae. |
| [4] |
Liu X, Jin X, Ou H, Qian C, Wu H, et al. 2022. The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer. |
| [5] |
Farrow SC, Hagel JM, Facchini PJ. 2012. Transcript and metabolite profiling in cell cultures of 18 plant species that produce benzylisoquinoline alkaloids. |
| [6] |
Tian Y, Kong L, Li Q, Wang Y, Wang Y, et al. 2024. Structural diversity, evolutionary origin, and metabolic engineering of plant specialized benzylisoquinoline alkaloids. |
| [7] |
An Z, Gao R, Chen S, Tian Y, Li Q, et al. 2024. Lineage-specific CYP80 expansion and benzylisoquinoline alkaloid diversity in early-diverging eudicots. |
| [8] |
Yusupov MM, Karimov A, Shakirov R, Gorovoi PG, Faskhutdinov MF, et al. 1993. Berberis alkaloids. XXVI. An investigation of the alkaloids of Berberis amurensis. |
| [9] |
Roy NS, Choi IY, Um T, Jeon MJ, Kim BY, et al. 2021. Gene expression and isoform identification of PacBio full-length cDNA sequences for berberine biosynthesis in Berberis koreana. |
| [10] |
Fan RF, Li HT, Kuang HY, Li W. 2019. Huanglumu de Sheng Yao Xue Yan Jiu ji Yan Suan Xiao Bo Jiang de Han Liang Ce Ding (黄芦木的生药学研究及盐酸小檗碱的含量测定) [Pharmacognosical studies and content determination of berberine hydrochloride of Berberis amurensis Rupr]. |
| [11] |
Srivastava S, Srivastava M, Misra A, Pandey G, Rawat A. 2015. A review on biological and chemical diversity in Berberis (Berberidaceae). |
| [12] |
Li T, Wang P, Guo W, Huang X, Tian X, et al. 2019. Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application. |
| [13] |
Wang K, Yin J, Chen J, Ma J, Si H, et al. 2024. Inhibition of inflammation by berberine: molecular mechanism and network pharmacology analysis. |
| [14] |
Jain S, Tripathi S, Tripathi PK. 2023. Antioxidant and antiarthritic potential of berberine: In vitro and in vivo studies. |
| [15] |
Zhao MM, Lu J, Li S, Wang H, Cao X, et al. 2021. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. |
| [16] |
Hu Y, Ehli EA, Kittelsrud J, Ronan PJ, Munger K, et al. 2012. Lipid-lowering effect of berberine in human subjects and rats. |
| [17] |
Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, et al. 2021. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota. |
| [18] |
Chen CY, Zhang Y. 2025. Berberine: An isoquinoline alkaloid targeting the oxidative stress and gut-brain axis in the models of depression. |
| [19] |
Phogat A, Singh J, Malik V. 2024. Pharmacological effects of berberine – a Chinese medicine, against xenobiotics toxicity. |
| [20] |
Lagoa R, Silva J, Rodrigues JR, Bishayee A. 2020. Advances in phytochemical delivery systems for improved anticancer activity. |
| [21] |
Yi LT, Zhu JX, Dong SQ, Chen M, Li CF. 2021. Berberine exerts antidepressant-like effects via regulating miR-34a-synaptotagmin1/Bcl-2 axis. |
| [22] |
Bao S, Wang X, Ma Q, Wei C, Nan J, et al. 2022. Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation. |
| [23] |
Zhang C, Song Y, Sun X, Liu Q, Li Z, et al. 2023. Photoredox-catalyzed reaction as a powerful tool for rapid natural product Gem-dimethylation modification: discovery of potent anti-cancer agents with improved druggability. |
| [24] |
Sun C, Sha S, Shan Y, Gao X, Li L, et al. 2025. Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer's disease. |
| [25] |
Lei Y, Xie J, Xie Z, Zhao X, Huang J, et al. 2025. Comparative drug-drug interactions of berberine and astragaloside IV in normal and type 2 diabetes mellitus rats based on UPLC-QqQ-MS/MS. |
| [26] |
Liu Y, Wang B, Shu S, Li Z, Song C, et al. 2021. Analysis of the Coptis chinensis genome reveals the diversification of protoberberine-type alkaloids. |
| [27] |
He SM, Liang YL, Cong K, Chen G, Zhao X, et al. 2018. Identification and characterization of genes involved in benzylisoquinoline alkaloid biosynthesis in Coptis species. |
| [28] |
Guo L, Winzer T, Yang X, Li Y, Ning Z, et al. 2018. The opium poppy genome and morphinan production. |
| [29] |
Hagel JM, Beaudoin GAW, Fossati E, Ekins A, Martin VJJ, et al. 2012. Characterization of a flavoprotein oxidase from opium poppy catalyzing the final steps in sanguinarine and papaverine biosynthesis. |
| [30] |
Yang H, Liu Z, Yu C, Song C, Wang C. 2023. Expression relationship between microRNA and transcription factors in Stephania japonica. |
| [31] |
Liu T, Zhang W, Wang S, Tian Y, Wang Y, et al. 2024. Metabolome and transcriptome association study reveals biosynthesis of specialized benzylisoquinoline alkaloids in Phellodendron amurense. |
| [32] |
Hagel JM, Facchini PJ. 2013. Benzylisoquinoline alkaloid metabolism: a century of discovery and a brave new world. |
| [33] |
Samanani N, Facchini PJ. 2002. Purification and characterization of norcoclaurine synthase. The first committed enzyme in benzylisoquinoline alkaloid biosynthesis in plants. |
| [34] |
Samanani N, Liscombe DK, Facchini PJ. 2004. Molecular cloning and characterization of norcoclaurine synthase, an enzyme catalyzing the first committed step in benzylisoquinoline alkaloid biosynthesis. |
| [35] |
Lee EJ, Facchini P. 2010. Norcoclaurine synthase is a member of the pathogenesis-related 10/Bet v1 protein family. |
| [36] |
Lee S, Park NI, Park Y, Park KC, Kim ES, et al. 2024. O- and N-Methyltransferases in benzylisoquinoline alkaloid producing plants. |
| [37] |
Wu L, Zhao B, Deng Z, Wang B, Yu Y. 2024. A biosynthetic network for protoberberine production in Coptis chinensis. |
| [38] |
Sato F, Tsujita T, Katagiri Y, Yoshida S, Yamada Y. 1994. Purification and characterization of S-adenosyl-ʟ-methionine: norcoclaurine 6-O-methyltransferase from cultured Coptis japonica cells. |
| [39] |
Choi KB, Morishige T, Shitan N, Yazaki K, Sato F. 2002. Molecular cloning and characterization of coclaurine N-methyltransferase from cultured cells of Coptis japonica. |
| [40] |
Pauli HH, Kutchan TM. 1998. Molecular cloning and functional heterologous expression of two alleles encoding (S)-N-methylcoclaurine 3'-hydroxylase (CYP80B1), a new methyl jasmonate-inducible cytochrome P-450-dependent mono-oxygenase of benzylisoquinoline alkaloid biosynthesis. |
| [41] |
Morishige T, Tsujita T, Yamada Y, Sato F. 2000. Molecular characterization of the S-adenosyl-L-methionine: 3'-hydroxy-N-methylcoclaurine 4'-O-methyltransferase involved in isoquinoline alkaloid biosynthesis in Coptis japonica. |
| [42] |
Huang P, Cheng P, Sun M, Liu X, Qing Z, et al. 2024. Systemic review of Macleaya cordata: genetics, biosynthesis of active ingredients and functions. Medicinal Plant Biology 3:e020 |
| [43] |
Xu Z, Li Z, Ren F, Gao R, Wang Z, et al. 2022. The genome of Corydalis reveals the evolution of benzylisoquinoline alkaloid biosynthesis in Ranunculales. |
| [44] |
Hafner J, Payne J, MohammadiPeyhani H, Hatzimanikatis V, Smolke C. 2021. A computational workflow for the expansion of heterologous biosynthetic pathways to natural product derivatives. |
| [45] |
Bu J, Zhang X, Li Q, Ma Y, Hu Z, et al. 2022. Catalytic promiscuity of O-methyltransferases from Corydalis yanhusuo leading to the structural diversity of benzylisoquinoline alkaloids. |
| [46] |
Ounaroon A, Decker G, Schmidt J, Lottspeich F, Kutchan TM. 2003. (R,S)-Reticuline 7-O-methyltransferase and (R,S)-norcoclaurine 6-O-methyltransferase of Papaver somniferum – cDNA cloning and characterization of methyl transfer enzymes of alkaloid biosynthesis in opium poppy. |
| [47] |
Li H, Wei W, Xu H. 2022. Drug discovery is an eternal challenge for the biomedical sciences. |
| [48] |
Li Q, Bu J, Ma Y, Yang J, Hu Z, et al. 2020. Characterization of O-methyltransferases involved in the biosynthesis of tetrandrine in Stephania tetrandra. |
| [49] |
Xu Z, Tian Y, Wang J, Ma Y, Li Q, et al. 2024. Convergent evolution of berberine biosynthesis. |
| [50] |
Leng L, Xu Z, Hong B, Zhao B, Tian Y, et al. 2024. Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery. |
| [51] |
Bi Z, Li H, Liang Y, Sun D, Liu S, et al. 2025. Emerging paradigms for target discovery of traditional medicines: a genome-wide pan-GPCR perspective. |
| [52] |
Raghavan V, Kraft L, Mesny F, Rigerte L. 2022. A simple guide to de novo transcriptome assembly and annotation. |
| [53] |
Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data. Bioinformatics 26(15):1968−71 |
| [54] |
Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, et al. 2011. Full-length transcriptome assembly from RNA-Seq data without a reference genome. |
| [55] |
Li W, Godzik A. 2006. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. |
| [56] |
Manni M, Berkeley MR, Seppey M, Simão FA, Zdobnov EM. 2021. BUSCO Update: novel and streamlined workflows along with broader and deeper phylogenetic coverage for scoring of eukaryotic, prokaryotic, and viral genomes. |
| [57] |
Cantalapiedra CP, Hernández-Plaza A, Letunic I, Bork P, Huerta-Cepas J. 2021. eggNOG-mapper v2: functional annotation, orthology assignments, and domain prediction at the metagenomic scale. |
| [58] |
Kanehisa M. 2016. KEGG bioinformatics resource for plant genomics and metabolomics. |
| [59] |
Ye J, Fang L, Zheng H, Zhang Y, Chen J, et al. 2006. WEGO: a web tool for plotting GO annotations. |
| [60] |
Hung JH, Weng Z. 2016. Sequence alignment and homology search with BLAST and ClustalW. |
| [61] |
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. 2018. MEGA X: molecular evolutionary genetics analysis across computing platforms. |
| [62] |
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. |
| [63] |
Chen C, Chen H, Zhang Y, Thomas HR, Frank MH, et al. 2020. TBtools: an integrative Toolkit developed for interactive analyses of big biological data. |
| [64] |
The Angiosperm Phylogeny Group, Chase MW, Christenhusz MJM, Fay MF, Byng JW, et al. 2016. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG IV. |
| [65] |
Zhong F, Huang L, Qi L, Ma Y, Yan Z. 2020. Full-length transcriptome analysis of Coptis deltoidea and identification of putative genes involved in benzylisoquinoline alkaloids biosynthesis based on combined sequencing platforms. |
| [66] |
Winzer T, Gazda V, He Z, Kaminski F, Kern M, et al. 2012. A Papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine. |
| [67] |
Menéndez-Perdomo IM, Facchini PJ. 2023. Elucidation of the (R)-enantiospecific benzylisoquinoline alkaloid biosynthetic pathways in sacred lotus (Nelumbo nucifera). |
| [68] |
Li F, Yuan Z, Gao Y, Deng Z, Zhang Y, et al. 2025. A concise enzyme cascade enables the manufacture of natural and halogenated protoberberine alkaloids. |
| [69] |
Han J, Li S. 2023. De novo biosynthesis of berberine and halogenated benzylisoquinoline alkaloids in Saccharomyces cerevisiae. |
| [70] |
Jiao X, Fu X, Li Q, Bu J, Liu X, et al. 2024. De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast. |